Clinical Trial Update: A Multiple Dose Trial of Emraclidine in Elderly Participants and in Participants With Dementia Due to Alzheimer's Disease [Phase 1]

View source ↗

Summary

Phase 1 multiple-dose trial of Emraclidine in elderly participants and in participants with Alzheimer's disease dementia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Emraclidine (Emraclidine)

Snippet

Sponsor: AbbVie | Conditions: Healthy Participants, Alzheimer's Disease Dementia | Phase 1 | Status: COMPLETED